Beryl Drugs Ltd — Important, 06-01-2026: Company Update

Beryl Drugs Limited has filed its quarterly compliance report for dematerialized securities. The company confirmed that all shares received for dematerialization during the quarter ending 31st December, 2025, were processed accurately and promptly. This includes confirming their status to depositories, ensuring they are listed, and updating the register of members by substituting depository names within the required timeframe after verifying and cancelling physical certificates. This update assures investors of robust share transfer and record-keeping processes, maintaining the integrity of share transactions.